Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
595
First IPO Date
December 19, 2019
| Name | Title | Pay | Year Born |
| Zhi Bo Li | Deputy General Manager | 0 | 1973 |
| Dewei Yi | Chairman & GM | 0 | 1965 |
| Hao Xiong | Accounting Supervisor | 0 | N/A |
| Xiangyu Li | Deputy General Manager | 0 | 1978 |
| Huabiao Wang | Financial Director & Director | 0 | 1965 |
| Huarong Yi | Deputy GM & Secretary of the Board of Directors | 0 | 1976 |
| Anfeng Geng | Deputy General Manager | 0 | 1976 |
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.